ad
This Article
Right arrow Full Version
Right arrow PDF Español
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Section 1. Active and Passive Immunization

IMMUNIZATION IN SPECIAL CLINICAL CIRCUMSTANCES

Immunocompromised Children

PRIMARY AND SECONDARY IMMUNE DEFICIENCIES
CORTICOSTEROIDS
HODGKIN DISEASE
BONE MARROW TRANSPLANT RECIPIENTS
SOLID ORGAN TRANSPLANT RECIPIENTS
HUMAN IMMUNODEFICIENCY VIRUS INFECTION (SEE ALSO HUMAN IMMUNODEFICIENCY VIRUS INFECTION, P 360)
ASPLENIC CHILDREN

PRIMARY AND SECONDARY IMMUNE DEFICIENCIES

The safety and effectiveness of vaccines in people with immune deficiency are determined by the nature and degree of immunosuppression. Immunocompromised people vary in their degree of immunosuppression and susceptibility to infection. Immunocompromised children represent a heterogeneous population with regard to immunization. Immunodeficiency conditions can be grouped into primary and secondary (acquired) disorders. Primary disorders of the immune system generally are inherited and include disorders of B-lymphocyte (humoral) immunity, T-lymphocyte (cell)-mediated immunity, complement, and phagocytic function. Secondary disorders of the immune system are acquired and occur in people with human immunodeficiency virus (HIV) infection, acquired immunodeficiency syndrome, or malignant neoplasms; people who have undergone transplantation; and people receiving immunosuppressive or radiation therapy (see Table 1.13, p 71). Experience with vaccine administration in immunocompromised children is limited. In most situations, theoretic considerations are the only guide to vaccine administration, because experience with specific vaccines in people with a specific disorder is lacking. However, considerable data in HIV-infected infants provide reassurance about the low risk of adverse events in these patients after immunization.


Table 1.13. Immunization of Children and Adolescents With Primary and Secondary Immune Deficiencies

Live vaccines. In general, people who are severely immunocompromised or in whom immune status is uncertain should not receive live vaccines, either viral or bacterial, because of the risk of disease from the vaccine strains. Although precautions, contraindications, and suboptimal efficacy of immunizations in immunocompromised patients are emphasized, some immunocompromised children . . . [Go to Full Text]


Related Articles

Vaccine Safety and Contraindications
Red Book 2003 2003: 37-49. [Extract] [Full Text]

Scheduling Immunizations
Red Book 2003 2003: 21-23. [Extract] [Full Text]

Immune Globulin
Red Book 2003 2003: 54-56. [Extract] [Full Text]

Specific Immune Globulins
Red Book 2003 2003: 56. [Extract] [Full Text]

Children With Chronic Diseases
Red Book 2003 2003: 82. [Extract] [Full Text]

Poliovirus Infections
Red Book 2003 2003: 505-509. [Extract] [Full Text]

Rubella
Red Book 2003 2003: 536-541. [Extract] [Full Text]

Varicella-Zoster Infections
Red Book 2003 2003: 672-686. [Extract] [Full Text]

Haemophilus influenzae Infections
Red Book 2003 2003: 293-301. [Extract] [Full Text]

Hepatitis A
Red Book 2003 2003: 309-318. [Extract] [Full Text]

Human Immunodeficiency Virus Infection
Red Book 2003 2003: 360-382. [Extract] [Full Text]

Influenza
Red Book 2003 2003: 382-391. [Extract] [Full Text]

Measles
Red Book 2003 2003: 419-429. [Extract] [Full Text]

Meningococcal Infections
Red Book 2003 2003: 430-436. [Extract] [Full Text]

Mumps
Red Book 2003 2003: 439-443. [Extract] [Full Text]

Pneumococcal Infections
Red Book 2003 2003: 490-500. [Extract] [Full Text]